Skip to main content
Log in

Conversion of normal human lymphocytes to tumor-specific immunoreactivity by xenogeneic Immune RNA: Blastogenic responses to soluble tumor antigens

  • Original Papers
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Summary

Lymphocyte blastogenesis was used as an assay of Immune RNA (I-RNA) activity. Normal, non-immune human lymphocytes following incubation with xenogeneic antitumor I-RNA extracted from the lymphoid organs of specifically immunized sheep underwent blastogenesis when exposed to solubilized human tumor antigens in vitro. Blastogenic responses were, unexpectedly, relatively specific for the tumor type used to immunize the I-RNA donor sheep. No significant blastogenic responses were elicited by the I-RNA extracts or by the antigen preparations themselves. This study suggests that normal, human lymphocytes incubated (‘sensitized’) with I-RNA, in vitro, behave, in terms of antigen recognition, like lymphocytes which have previously been sensitized to tumor antigens and demonstrates that xenogeneic Immune RNA will mediate ‘afferent limb’ immune responses to human tumor antigens.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Cheema, A. R., Hersh, E. M.: Local tumor immunotherapy with in vitro activated autochthonous lymphocytes. Cancer 29, 982 (1972)

    Google Scholar 

  2. Fenster, J. H., Rogoway, W. M.: Immunotherapy of Human Neoplasms with Autologous Lymphocytes Activated in vitro. Proc. 5th Leukocyte Culture Conference, Harris, J. E. (ed.). New York: Academic Press 1971

    Google Scholar 

  3. Kern, D. H., Pilch, Y. H.: Immune cytolysis of murine tumor cells mediated by xenogeneic “Immune” RNA. Int. J. Cancer 13, 679 (1974)

    Google Scholar 

  4. Kern, D. H., Fritze, D., Drogemuller, C. R., Pilch, Y. H.: Mediation of cytotoxic immune responses against human tumor-associated antigens by xenogeneic “Immune” RNA. J. Natl. Cancer Inst. 57, 97 (1976)

    Google Scholar 

  5. Mavligit, G. M., Gutterman, J. U., McBride, C. M., Hersh, E. M.: Cell-mediated immunity to human solid tumors: In-vitro detection by lymphocyte blastogenic responses to cell-associated and solubilized tumor antigens. Natl. Cancer Inst. Monograph 37, 167 (1973)

    Google Scholar 

  6. Paque, R. E., Meltzer, M. S., Zbar, B., Rapp, H. J., Dray, S.: Transfer of tumor specific delayed hypersensitivity in vitro to normal guinea pigs peritoneal exudate cell using RNA extracts from sensitized lymphoid tissues. Cancer Res. 33, 3165 (1973)

    Google Scholar 

  7. Pilch, Y. H., Ramming, K. P., Deckers, D. J.: Studies in mediation of tumor immunity with “Immune” RNA. In: Methods in Cancer Research. Busch, H. (ed.), Vol. IX, p. 195. New York: Academic Press 1973

    Google Scholar 

  8. Ramming, K. P., Pilch, Y. H.: Transfer of tumor-specific immunity with RNA: Inhibition of growth of murine tumor iso-grafts. J. Natl. Cancer Inst. 6, 735 (1971)

    Google Scholar 

  9. Rosenberg, S. A., Levy, R.: A rapid assay of cell mediated immunity to soluble antigens based on the stimulation of protein synthesis. J. Immunol. 108, 1080 (1972)

    Google Scholar 

  10. Roth, J. A., Holmes, E. C., Boddie, A. W., Morton, A. L.: Lymphocyte responses of lung cancer patients to tumor-associated antigen measured by leucine incorporation. J. Thorac. Cardiovasc. Surg. 70, 613 (1975)

    Google Scholar 

  11. Roth, J. A., Holmes, E. C., Reisfeld, R. A., Slocum, H. K., Morton, D. L.: Isolation of a soluble tumor-associated antigen and human melanoma. Cancer 37, 104 (1976)

    Google Scholar 

  12. Roth, J. A., Grimm, E. A., Morton, D. L.: A rapid assay for stimulation of human lymphocytes by tumor-associated antigens. (submitted for publication)

  13. Schlager, S. I., Dray, S.: Tumor regression at an untreated site during immunotherapy of an identical distant tumor. Proc. Natl. Acad. Sci. USA 72, 3680 (1975)

    Google Scholar 

  14. Schlager, S. I., Paque, R. E., Dray, S.: Complete and apparently specific local tumor regression using syngeneic or xenogeneic “tumor-immune” RNA extracts. Cancer Res. 35, 1907 (1975)

    Google Scholar 

  15. Thurman, G. B., Strong, D. M., Ahmed, A., Green, S. S., Sell, K. W., Hartzman, R. J., Boch, F. H.: Human mixed lymphocyte cultures, evaluation of a microculture technique utilizing the multiple automated sample harvester (MASH). Clin. Exp. Immunol. 15, 289 (1973)

    Google Scholar 

  16. Viza, D., Phillips, J.: Extraction and solubilization of cell surface antigens from malignant melanomas. Rev. Inst. Pasteur, Lyon 4, 321 (1973)

    Google Scholar 

  17. Viza, D., Phillips, J.: Identification of an antigen associated with malignant melanoma. Int. J. Cancer 16, 312 (1975)

    Google Scholar 

  18. Waldman, S. R., Pilch, Y. H.: Specific MIF releases by rat lymphocytes following incubation with syngeneic anti-tumor “Immune” RNA. Cell. Immunol. 18, 246 (1975)

    Google Scholar 

  19. Wang, B. S., Stuart, P. A., Mannick, J. A.: Interspecies transfer by “Immune” RNA of lymphocyte proliferative response to specific antigen. Cell. Immunol. 12, 114 (1974)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Supported, in part, by Public Health Service Grant CA-18321 from the National Institute of Health

Rights and permissions

Reprints and permissions

About this article

Cite this article

Coates, M.R., Pilch, Y.H. Conversion of normal human lymphocytes to tumor-specific immunoreactivity by xenogeneic Immune RNA: Blastogenic responses to soluble tumor antigens. Cancer Immunol Immunother 3, 145–152 (1977). https://doi.org/10.1007/BF00200073

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00200073

Keywords

Navigation